Extinguishing maternal immune responses during pregnancy: implications for immunosuppression

Semin Immunol. 2001 Aug;13(4):213-8. doi: 10.1006/smim.2000.0317.

Abstract

Mammals owe their existence to immunosuppressive processes that prevent fetal rejection in utero. Blocking tryptophan catabolism during murine pregnancy allows maternal T cells to provoke fetal allograft rejection. Cells expressing indoleamine 2,3-dioxygenase (IDO), which catabolizes tryptophan, prevent T cell cycle progression and enhance activation induced T cell death. Here, we discuss the role of cells expressing IDO in regulating maternal T cell immunity during pregnancy and consider whether this mechanism might contribute to immunological discrimination by promoting T cell tolerance in other circumstances.

Publication types

  • Review

MeSH terms

  • Animals
  • Antigen-Presenting Cells / immunology
  • Cell Death
  • Female
  • Humans
  • Immune Tolerance*
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Lymphocyte Activation
  • Maternal-Fetal Exchange / immunology
  • Mice
  • Pregnancy / immunology*
  • Pregnancy / metabolism
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Tryptophan / immunology
  • Tryptophan / metabolism
  • Tryptophan Oxygenase / metabolism

Substances

  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Tryptophan
  • Tryptophan Oxygenase